Fuso Pharmaceutical Industries,Ltd. (4538) Stock Price

Fuso Pharmaceutical Industries operates two main business segments: pharmaceuticals and real estate. The company manufactures and sells pharmaceutical products for medical use and medical devices, with injectable products centered on intravenous solutions and dialysate for artificial kidneys as core offerings. The company also provides contract manufacturing services for pharmaceutical products.

In the real estate segment, Fuso Pharmaceutical Industries engages in property leasing. This business serves as a separate revenue stream distinct from pharmaceuticals, diversifying the company's business portfolio. Through this diversification, the company has established a stable revenue base.

Fuso Pharmaceutical Industries is a pharmaceutical manufacturer with prescription drugs as its core business. The company prioritizes product development and stable supply in response to an aging society and advances in medical technology. As a pillar of its medium-term strategy, the company focuses on meeting demand for blood and body fluid medications and dialysate for artificial kidneys, while improving productivity at its Okayama and Ibaraki factories.

The company does not set specific management targets. Instead, it pursues sustained improvement in corporate value by comprehensively considering financial soundness, profitability, and growth. The company is developing products that address new medical needs and aims to establish a new core product line following its dialysis-related products.

Fuso Pharmaceutical Industries has established a stable supply system prepared for natural disasters and pandemics. By dispersing manufacturing facilities across eastern and western regions and maintaining product storage facilities in multiple locations, the company secures inventory capable of responding to unexpected demand. While managing rising logistics costs, the company is focusing on strengthening sales and developing new dialysate products.

The company maintains rigorous quality control and leverages its brand strength and expertise to undertake contract manufacturing for other companies, creating new revenue streams. The company is advancing into new business areas to efficiently utilize management resources and reduce product cost ratios. Through these efforts, the company aims to enhance corporate value.